ERAS: the cashflow

MyFinsight

For the quarter ending 2025-09-30.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Net loss	-95,454	-64,842
Depreciation and amortization	2,364	1,609
Stock-based compensation expense	19,076	13,111
In-process research and development expenses	9,500	7,500
Accretion on marketable securities, net	4,507	3,485
Prepaid expenses and other current and long-term assets	387	-516
Accounts payable	2,561	1,195
Accrued expenses and other current and long-term liabilities	-5,438	-6,628
Operating lease assets and liabilities, net	1,459	1,062
Net cash used in operating activities	-73,744	-52,086
Purchases of marketable securities	108,744	67,204
Maturities of marketable securities	194,077	122,827
In-process research and development	9,500	5,500
Purchases of property and equipment	119	113
Net cash provided by (used in) investing activities	75,714	50,010
Proceeds from the exercise of stock options	117	76
Proceeds from issuance of common stock under the employee stock purchase plan	404	404
Net cash provided by financing activities	521	480
Net increase (decrease) in cash, cash equivalents and restricted cash	2,491	-1,596
Cash and cash equivalents at beginning of period	68,147	-
Cash and cash equivalents at end of period	70,638	-

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

ERAS: the cashflow